Stamoulis Christiana's most recent trade in Hologic, Inc. was a trade of 3,190 Common Stock done . Disclosure was reported to the exchange on Feb. 26, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Hologic | Christiana Stamoulis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2026 | 3,190 | 50,526 (0%) | 0% | - | Common Stock | |
| Hologic | Christiana Stamoulis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.04 per share. | 20 Oct 2025 | 7,402 | 54,738 (0%) | 0% | 36.0 | 266,768 | Common Stock |
| Hologic | Christiana Stamoulis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2025 | 7,402 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic | Christiana Stamoulis | Director | Sale of securities on an exchange or to another person at price $ 73.07 per share. | 20 Oct 2025 | 7,402 | 47,336 (0%) | 0% | 73.1 | 540,864 | Common Stock |
| Incyte | Christiana Stamoulis | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 27,769 | 27,769 | - | - | Performance Shares | |
| Incyte | Christiana Stamoulis | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 24,998 | 24,998 | - | - | Employee Stock Option (right to buy) | |
| Incyte | Christiana Stamoulis | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 11,107 | 125,759 (0%) | 0% | 0 | Common Stock | |
| Incyte | Christiana Stamoulis | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.25 per share. | 14 Jul 2025 | 1,445 | 114,652 (0%) | 0% | 68.2 | 98,621 | Common Stock |
| Incyte | Christiana Stamoulis | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.98 per share. | 14 Jul 2025 | 1,407 | 116,097 (0%) | 0% | 70.0 | 98,462 | Common Stock |
| Incyte | Christiana Stamoulis | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.17 per share. | 02 Jul 2025 | 11,589 | 117,504 (0%) | 0% | 68.2 | 790,022 | Common Stock |
| Incyte | Christiana Stamoulis | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 18,970 | 129,093 (0%) | 0% | 0 | Common Stock | |
| Incyte | Christiana Stamoulis | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 18,598 | 110,123 (0%) | 0% | 0 | Common Stock | |
| Hologic | Christiana Stamoulis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 5,535 | 5,535 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic | Christiana Stamoulis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 1,864 | 47,336 (0%) | 0% | - | Common Stock | |
| Incyte | Christiana Stamoulis | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 25,516 | 25,516 | - | - | Employee Stock Option (right to buy) | |
| Incyte | Christiana Stamoulis | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.46 per share. | 15 Jan 2025 | 3,672 | 91,525 (0%) | 0% | 72.5 | 266,073 | Common Stock |
| Hologic | Christiana Stamoulis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 9,039 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic | Christiana Stamoulis | Director | Sale of securities on an exchange or to another person at price $ 79.50 per share. | 17 Jul 2024 | 9,039 | 45,472 (0%) | 0% | 79.5 | 718,601 | Common Stock |
| Hologic | Christiana Stamoulis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.74 per share. | 17 Jul 2024 | 9,039 | 54,511 (0%) | 0% | 26.7 | 241,703 | Common Stock |
| Incyte | Christiana Stamoulis | EVP & Chief Financial Officer | 15 Jul 2024 | 28,127 | 28,127 | - | - | Employee Stock Option (right to buy) | ||
| Incyte | Christiana Stamoulis | EVP & Chief Financial Officer | 15 Jul 2024 | 12,572 | 96,145 (0%) | 0% | 0 | Common Stock | ||
| Incyte | Christiana Stamoulis | EVP & Chief Financial Officer | 15 Jul 2024 | 948 | 95,197 (0%) | 0% | 64.3 | 60,909 | Common Stock | |
| Incyte | Christiana Stamoulis | EVP & Chief Financial Officer | 02 Jul 2024 | 6,870 | 83,573 (0%) | 0% | 59.0 | 405,467 | Common Stock | |
| Hologic | Christiana Stamoulis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 4,536 | 4,536 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic | Christiana Stamoulis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 1,572 | 45,472 (0%) | 0% | - | Common Stock | |
| Incyte | Stamoulis Christiana | EVP & Chief Financial Officer | 14 Feb 2024 | 7,377 | 89,983 (0%) | 0% | 0 | Common Stock | ||
| Incyte | Christiana Stamoulis | EVP & Chief Financial Officer | 12 Feb 2024 | 387 | 82,606 (0%) | 0% | 57.8 | 22,384 | Common Stock | |
| Incyte | Stamoulis Christiana | EVP & Chief Financial Officer | 18 Jan 2024 | 27,668 | 27,668 | - | - | Employee Stock Option (right to buy) | ||
| Incyte | Christiana Stamoulis | EVP & Chief Financial Officer | 14 Jul 2023 | 25,682 | 25,682 | - | - | Employee Stock Option (right to buy) | ||
| Incyte | Christiana Stamoulis | EVP & Chief Financial Officer | 14 Jul 2023 | 12,246 | 82,993 (0%) | 0% | 0 | Common Stock | ||
| Incyte | Christiana Stamoulis | EVP & Chief Financial Officer | 03 Jul 2023 | 6,073 | 70,747 (0%) | 0% | 62.1 | 377,012 | Common Stock | |
| Hologic | Christiana Stamoulis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2023 | 4,210 | 4,210 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic | Christiana Stamoulis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2023 | 1,465 | 43,900 (0%) | 0% | - | Common Stock | |
| Incyte | Christiana Stamoulis | EVP & Chief Financial Officer | 13 Feb 2023 | 848 | 76,791 (0%) | 0% | 80.1 | 67,908 | Common Stock | |
| Incyte | Christiana Stamoulis | EVP & Chief Financial Officer | 13 Feb 2023 | 331 | 76,460 (0%) | 0% | 80.1 | 26,506 | Common Stock | |
| Incyte | Christiana Stamoulis | EVP & Chief Financial Officer | 20 Jan 2023 | 24,515 | 24,515 | - | - | Employee Stock Option (right to buy) | ||
| Incyte | Christiana Stamoulis | EVP & Chief Financial Officer | 20 Jan 2023 | 4,980 | 77,639 (0%) | 0% | 0 | Common Stock | ||
| Incyte | Christiana Stamoulis | EVP & Chief Financial Officer | 02 Jul 2022 | 23,221 | 23,221 | - | - | Employee Stock Option (right to buy) | ||
| Incyte | Christiana Stamoulis | EVP & Chief Financial Officer | 02 Jul 2022 | 17,317 | 73,783 (0%) | 0% | 0 | Common Stock | ||
| Incyte | Christiana Stamoulis | EVP & Chief Financial Officer | 02 Jul 2022 | 1,124 | 72,659 (0%) | 0% | 79.3 | 89,077 | Common Stock | |
| Hologic | Christiana Stamoulis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 5,293 | 5,293 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic | Christiana Stamoulis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 1,565 | 42,435 (0%) | 0% | - | Common Stock | |
| Incyte | Christiana Stamoulis | EVP & Chief Financial Officer | 11 Feb 2022 | 846 | 56,616 (0%) | 0% | 66.8 | 56,479 | Common Stock | |
| Incyte | Christiana Stamoulis | EVP & Chief Financial Officer | 11 Feb 2022 | 331 | 56,285 (0%) | 0% | 66.8 | 22,098 | Common Stock | |
| Incyte | Christiana Stamoulis | EVP & Chief Financial Officer | 19 Jan 2022 | 15,054 | 15,054 | - | - | Employee Stock Option (right to buy) | ||
| Incyte | Christiana Stamoulis | EVP & Chief Financial Officer | 01 Jan 2022 | 14,463 | 57,462 (0%) | 0% | 0 | Common Stock | ||
| Incyte | Christiana Stamoulis | EVP & Chief Financial Officer | 19 Nov 2021 | 2,355 | 42,999 (0%) | 0% | 0 | Common Stock | ||
| Incyte | Christiana Stamoulis | EVP & Chief Financial Officer | 19 Nov 2021 | 379 | 40,644 (0%) | 0% | 0 | Common Stock | ||
| Incyte | Christiana Stamoulis | EVP & Chief Financial Officer | 02 Jul 2021 | 15,054 | 15,054 | - | - | Employee Stock Option (right to buy) | ||
| Incyte | Christiana Stamoulis | EVP & Chief Financial Officer | 02 Jul 2021 | 7,853 | 40,781 (0%) | 0% | 0 | Common Stock | ||
| Incyte | Christiana Stamoulis | EVP & Chief Financial Officer | 02 Jul 2021 | 516 | 40,265 (0%) | 0% | 0 | Common Stock |